Results 171 to 180 of about 110,931 (189)

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

Annals of Oncology, 2016
Michitaka Nagase, I Hyodo, T Denda
exaly  

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Annals of Oncology, 2015
A Kollar, R von Moos, M Frueh
exaly  

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Oncologist, 2012
Javier Sastre, Marta Llanos Munoz
exaly  

Management of bevacizumab-associated bowel perforation: a case series and review of the literature

Annals of Oncology, 2008
Charis Eng, L M Ellis, J N Cormier
exaly  

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Annals of Oncology, 2009
David Cunningham, J ‐L Canon, A Kretzschmar   +2 more
exaly  

Bevacizumab

Reactions Weekly, 2009
openaire   +1 more source

Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles

Journal of Controlled Release, 2019
Bruno Sarmento, Mansoor Amiji, Flavia Sousa   +2 more
exaly  

The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review

Biomedicine and Pharmacotherapy, 2018
Dinesh Kumar Chellappan, Gaurav Gupta, Jestin Chellian   +2 more
exaly  

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Annals of Oncology, 2013
Robert Benjamin, Andrew Evens, M von Mehren   +2 more
exaly  

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

Annals of Oncology, 2013
A Jakobsen, A Berglund, J Sundberg
exaly